Abstract Pluripotent stem cells (PSCs) are a useful source of cells for exploring the role of genes related with early developmental processes and specific diseases due to their ability to differentiate into all somatic cell types. Recently, the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) protein 9 system has proven to be a robust tool for targeted genetic modification. Here, we generated miR-451-deficient PSCs using the CRISPR/Cas9 system with PCR-based homologous recombination donor and investigated the impact of its deletion on self-renewal and hematopoietic development. CRISPR/Cas9-mediated miR-451 knockout did not alter the gene expressions of pluripotency, cellular morphology, and cell cycle, but led to impaired erythrocyte development. These findings propose that a combination of PSCs and CRISPR/Cas9 system could be useful to promote biomedical applications of PSCs by elucidating the function and manipulating of specific miRNAs during lineage specification and commitment.
Introduction
Pluripotent stem cells (PSCs) hold great promise for treating various diseases and understanding early developmental processes due to their ability to self-renew indefinitely and differentiate into all somatic cell types [1, 2] . Accumulating evidence indicates that microRNAs (miRNAs), short non-coding RNAs of approximately 18-22 nucleotides, are participated in regulating self-renewal and differentiation of PSCs [3] [4] [5] [6] . In this respect, understanding the function of miRNAs governing PSC specification and commitment into specific lineages is required for their biomedical applications, which can be accomplished by a simple, precise, and highly efficient knockout system of a miRNA of interest in PSCs.
Recently, the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) protein 9 system has proven to be a robust tool for genome editing [7] [8] [9] [10] . This system directs the Cas9 nuclease to a desired genomic locus by a chimeric synthetic single-guide RNA (gRNA) and results in introduction of double-strand breaks for genome editing [7, 8] . Currently, CRISPR/Cas9 technique has the most attention as a simple and highly efficient knockout strategy to target specific genomic loci in various cell lines and species in comparison with other methods such as zinc finger nuclease (ZFN) and transcription activator-like effector nuclease (TALEN) [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . For instances, CRISPR/Cas9 system is able to target nearly any sequence in the genome by designing of gRNA. In particular, this system can eliminate the laborious processes of other methods by directly injecting RNAs encoding the Cas9 protein and gRNA into viable mouse embryos to create targeted mutant mice. In addition, mutations in multiple genes can be simultaneously achieved by injecting multiple gRNAs [17] . Recent studies reported the successful application of the CRISPR/Cas9 technique in PSCs including embryonic stem cells (ESCs) and induced PSCs (iPSCs) to reveal the role of specific mRNAs in PSC self-renewal and differentiation as well as replacement of mutant sequences with correct one [18] [19] [20] [21] . However, few studies have been carried out to investigate the function of specific miRNAs in PSCs [22] .
We previously identified erythroid lineage-specific miRNAs including miR-451 regulated during in vitro erythropoiesis of human umbilical cord-and human ESC-derived CD34? cells [5] . Interestingly, miR-451 plays a negative regulatory role for erythropoiesis in Zebrafish [23] . Thus, here we generated homozygous miR-451 knockout (miR-451 KO) mouse ESC line using the CRISPR/Cas9 system with PCR-based homologous recombination donor and analyzed their self-renewal activity and hematopoietic differentiation potential. MiR-451 KO mESCs exhibited similar characteristics to its wild-type (WT) counterpart regarding the gene expressions of pluripotency, cellular morphology, and cell cycle. Interestingly, we found that miR-451 KO mESCs gave rise to much more hematopoietic progenitor cells (HPCs). However, we observed significant defect of miR-451 KO mESC-derived HPCs in generating blast forming unit-erythrocyte (BFU-E). Our findings suggest that combination of PSCs and CRISPR/Cas9 system could be useful to promote biomedical applications of PSCs and understand the intricate regulatory mechanisms of PSC differentiation by elucidating the function of specific miRNAs during lineage specification and commitment. 
Cell culture and DNA transfection
CCE mESCs were maintained on irradiated mouse embryonic fibroblast (MEF) in DMEM containing 15% fetal bovine serum (FBS; Hyclone), 10 3 unit/ml leukemia inhibitory factor (LIF, Merck Millipore), 0.1 mM b-mercaptoethanol (Gibco), 1% non-essential amino acids (NEAA; Gibco), 1x penicillin/streptomycin, and 1x GlutaMax (Gibco). Cells were passaged every 2-3 days and changed with fresh medium every other day. DNA transfection was performed with lipofectamine 2000 (Invitrogen).
Establishment of miR-451 KO mESC lines
PCR-based homologous recombination donor and two nickases were transfected to parental CCE cells and were selected with 3 g/ml puromycin (Sigma) for a week. The puromycin-resistant colonies were isolated and cultured with 1 lg/ml puromycin further.
Verification of miR-451 KO mESC lines by genomic sequencing and RT-PCR
Genomic DNA was extracted using a rapid method [24] . The samples were suspended in 500 ll lysis buffer [10 mM Tris (pH 8.0), 10 mM EDTA, and 2% SDS], and 50 ll 10% SDS was added followed by 5-10 ll 20 mg/ml proteinase K. The samples were incubated for 1 h at 56°C. Genomic DNA was isolated using mini-prep DNA column. To identify HR donor insertion by homologous recombination, 5' and 3' gene-specific primers were chosen from the adjacent upstream and downstream of the HR destination site. Genomic PCR was performed using EF-taq (Solgent).
RT-PCR primers are Forward primer: ACA GGA TCA GGG AGA TGC TGC T, Reverse: ACT CTG ACT GGC TGG CTA TCT CTA. All genomic PCR products were analyzed by sequencing.
BrdU assay
WT and miR-451 KO mESCs were treated with 10 lM of bromodeoxyuridine (BrdU) for 4 h before being harvested and then fixed in 70% ethanol. Cells were stained with allophycoerythrin (APC)-conjugated anti-BrdU antibody and 7-amino actinomycin (7ADD) using APC-BrdU Flow Kit (BD Pharmingen). Flow cytometric analysis was performed by using FACSCantoII flow cytometer (BD Biosciences) and resultant data were analyzed by the FlowJo software (Tree Star).
Hematopoietic differentiation
Prior to the embryoid body (EB) formation, WT and miR-451 KO mESCs were pre-differentiated in IMDM medium with 10 ng/ml of LIF. The pre-differentiated cells were replated in bacterial petri dished with 1,500 cells/ml concentration. On the following day, EBs were resuspended in StemPro34 media (Life Technologies) supplemented with StemPro34 supplement, 2 mM L-glutamine (Life Technologies), 50 lg/mL L-ascorbic acid (Sigma Aldrich), 200 lg/mL transferrin (Sigma Aldrich), 4 9 10 -4 M monothioglycerol (Life Technologies) and 4 ng/mL BMP4 (R&D systems). After 2.5 days, the EBs were treated with 5 ng/mL FGF2 (Life Technologies), 5 ng/mL Activin A (R&D systems), 5 ng/mL VEGF (R&D systems), 20 ng/mL TPO (R&D systems) and 100 ng/mL SCF (R&D systems) for 4-8 days. The colony forming unit (CFU) assay was performed by plating single cells (25,000 cells per well of 24-well non-tissue culture plate) in methylcellulose (M3434, Stem Cell Technologies, Inc). The colonies were scored after 10 days.
Flow cytometry
Single cell suspensions were harvested from mESC cultures by dissociation with 0.05% trypsin-EDTA and resuspended in 1% FBS-PBS. The cells were filtered through a 70lm cell strainer and incubated for 30 min at 4°C with CD41-fluorescein-isothiocyanate (FITC) and CD117-APC antibodies. After staining, the cells were rinsed once and stained with 7AAD to exclude dead cells. For intracellular staining of Oct4, Sox2 and Nanog, the Cytofix/Cytoperm buffer (BD Biosciences) was used according to the manufacturer's instructions. All antibodies were purchased from BD Biosciences. Flow cytometric analysis was performed by using FACSCanto II flow cytometer and acquired data were analyzed by the FlowJo software.
Statistical analysis
Values for all measurements were presented as mean± SD. Statistical significance was determined using Student's ttest and p\0.05 was considered statistically significant.
Results

Establishment of miR-451 KO ESCs by CRISPR/Cas9 nickase with HR donor
To remove miR-451 gene in parental CCE mESCs, we used the Cas9 D10A nickase pair for reducing the offtarget effects of wt Cas9 nuclease [25] . Usually, genetic exchange takes place between a pair of homologous DNA sequences [26] . We therefore designed the HR donor arms containing 150bp gene-specific sequences that occur in the HR event between identical miR-451 genomic region and amplified PGK-Puro HR cassette (Fig. 1A) . As anticipated, nickase pairs with HR donor can lead to precise homologous recombination event based on our sequencing data (Fig. 1B, C) . In addition, pri-miR-451 transcripts were not expressed in miR-451 KO mESCs (Fig. 1D ).
Analysis of the effects of miR-451 deficiency in mESCs
We first asked if miR-451 deficiency causes the defects in the self-renewal and proliferation of mESCs. WT and miR-451 KO mESCs were maintained for long term (more than 10 passages) under same undifferentiated condition and did not show any significant changes to their colony morphology ( Fig. 2A) (Fig. 2B) . To determine whether miR-451 is associated with proliferative potential and specific phases of the cell cycle, we performed a BrdU assay where the cells were exposed to BrdU for 4 hrs prior to cell counting and measuring the cell cycle distribution. Knockout of miR-451 had no significant effect on the cellular proliferation (Fig. 2C) . We also found a similar proportion of G0/G1, S and G2/M phases between two cell types (Fig. 2 D) . These results indicate that miR-451 is not critical for maintenance of undifferentiated state and proliferation of mESCs.
MiR-451 is involved in regulating early hematopoiesis
To determine if miR-451 is associated with differentiation potential, we generated EBs from WT and miR-451 KO mESCs and cultured for 10 days under established conditions for hematopoietic differentiation [27] . There was no significant difference in EB formation and shape between two cell types during hematopoietic differentiation (Fig.  3A) . At days 6, 8 and 10 of hematopoietic differentiation, dissociated EBs were analyzed by flow cytometry to determine the frequency of definitive hematopoietic cells (CD41?) and hematopoietic progenitor cells (HPCs, CD41?CD117?). There was no significant difference in the frequency of CD41? and CD41?CD117? cells between two cell types at day 6 of hematopoietic differentiation. However, the frequencies of CD41? and CD41?CD117? cells were significantly increased in miR-451 KO-derived EBs compared to WT-derived EBs at days 8 and 10 ( Fig. 3B, C) . We further conducted a functional CFU assay to compare multilineage hematopoietic progenitor potential derived from WT-and miR-451 KOderived EBs. While no difference in the number of CFU-GM, miR-451 KO-derived HPCs were defective in generating BFU-E colony compared to WT-derived HPCs (Fig. 3D) . These results suggest that early hematopoietic and erythropoietic development can be regulated by modulating of miR-451 expression.
Discussion
The understanding of the regulatory mechanism of miRNAs in self-renewal and differentiation of PSCs is of crucial importance for their basic and clinical use. RNA interference (RNAi) technology including short-interfering RNA and short-hairpin RNA to reduce expression of specific miRNAs have been widely used in vitro and in vivo [28] . However, these methods have several limits to completely knockout of miRNAs due to their low efficiency and undesirable off-target effects. Recent advanced gene editing technique, called CRISPR/Cas9 system has some advantages over other methods such as RNAi, ZFN, and TALEN and currently has the most attention as a simple and highly efficient genome editing strategy to target specific genomic loci in various cell types and species [7-13, 15, 16] . Here, we employed the CRISPR/Cas9 system to generate miR-451 KO mESC clones and elucidated that miR-451 is associated with early hematopoietic and erythroid differentiation from mESCs in vitro. To our best knowledge, it is the first report to demonstrate the role of specific miRNA during PSCderived hematopoiesis using CRISPR/Cas9 system. Our study proposes that combination of PSCs and CRISPR/ Cas9 system could be useful to modulate specific miRNAs for understanding their regulatory mechanisms in early embryonic development and promoting clinical applications of PSCs. Previous studies have reported the crucial function of miR-451 in erythroid differentiation, which is conserved among several species. In wild-type zebrafish embryos, morpholino knockdown of miR-451 has no effects on initiation of early erythroid differentiation, but retards erythrocyte maturation [23] . Overexpression of miR-451 mutant zebrafish embryos partially rescues erythrocyte maturation via targeting of gata-2 mRNA [29] . Similarly, transplantation of mouse HPCs transduced with miR-451 inhibitory lentiviral constructs into mouse bone marrow (BM) displayed markedly reduced Ter119? erythroblast cells in the BM [30] . Several groups have generated miR-451 knockout mice, which exhibited a reduction in hematocrit and impairment of late erythroblast maturation in BM and spleen [31] [32] [33] . It has been also reported that miR-451 is involved in promoting erythroid maturation of HPCs (CD133? or CD34? cells) derived from human umbilical cord and peripheral blood via strong induction of b-globin expression [34] [35] [36] . Consistent with previous findings, our study showed that miR-451 deficiency in mESCs results in reduction of an early erythroid progenitor subset that contains to BFU-E cells. Moreover, we found that miR-451 KO in mESCs led to a significant increase of early HPC populations (CD41? and CD41?CD117?), suggestive of miR-451 as a potential erythrocytic inducer during hematopoietic differentiation.
Taken together, our study elucidates that miR-451 is essential for early hematopoietic and erythroid differentiation from mESCs and suggests that CRISPR/Cas9-based genomic editing technique could be a highly efficient and robust tool for determining the role of specific miRNA and genetically manipulating cell fate determination of PSCs. Further studies will be needed to reveal the detailed regulatory mechanism of miR-451 in PSC hematopoietic differentiation.
